Glycaemic control in patients with type 2 diabetes treated with oral antidiabetic drugs in urban areas of China
Ju-ming LU,Li-nong JI,Xiao-hui GUO,Wen-ying YANG,Jian-ping WENG,Wei-ping JIA,Da-jin ZOU,Zhi-guang ZHOU,De-min YU,Jie LIU,Zhong-yan SHAN,Yu-zhi YANG,Ren-ming HU,Da-long ZHU,Li-yong YANG,Li CHEN,Zhi-gang ZHAO,Qi-fu LI,Hao-ming TIAN,Qiu-he JI,Jing LIU,Jia-pu GE,Li-xin SHI,Yan-cheng XU
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2012.07.005
2012-01-01
Abstract:Objective To investigate glycemic control,treatment regimen and other relevant characteristics in patients with type 2 diabetes mellitus( T2DM ) treated with oral antidiabetic drugs (OADs)only in urban areas of China.Methods A total of 414 hospitals from 81 cities across China participated in the survey.Outpatients with T2DM on OADs treatment only were eligible for this study.General information of patients,medical history for T2DM,laboratory investigations and treatment regimen were collected from July to September in 2010.Logistic regression analysis was applied in the correlation analysis of glycemic control.Results A total of 97 315 eligible patients with T2DM were included in this study,with a mean age of (59 ± 11 ) years and a mean diabetes duration of (5 ±4) years.The mean glycated hemoglobin A1c (HbA1c) level of all patients was 7.7％ ± 1.6％.Total of 35.1％ (34 154 cases) and 17.9％ ( 17 380 cases) of the patients had a HbA1 c ＜ 7.0％ and ＜ 6.5％,respectively.Among all the patients,13.1％ ( 12 748 cases) complicated with at least one macrovascular disease,and 15.1％ ( 14 694 cases) with at least one microvascular disease. Of the patients with macrovascular complication ( s ),27.3％ achieved optimal glycemic target (HbA1c ＜ 7.0％ ),it was lower than that in patients without macrovascular complication(s) (36.3％ ).Similarly,25.2％ of the patients with microvascular complication(s) achieved optimal glycemic target and it was lower than that in patients without microvascular complication (s)( 36.9％ ).Among all the OAD treatment regimens,two kinds of OADs ( 51.3％ ) and one OAD ( 34.5％ )were most frequently used.It's found that 40.6％,33.7％,27.0％ and 24.5％ of the patients receiving one OAD,two OADs,three OADs and four or more OADs achieved glycemic control target,respectively.The most frequently used OADs were biguanides ( 30.8％ ),sulphonylureas ( 24.6％ ) and glinides (21.1％).Among the combined treatment regimens,23.7％ were biguanides plus sulphonylureas,13.6％were biguanides plus glinides.Regression analysis showed that male,duration of diabetes,kinds of OADs,body mass index,combined with macro or micro vascular diseases were inversely associated with rate of achieving HbA1 c target (OR =1.025,0.855,0.868,0.852,0.789,0.698,all P ＜ 0.01 ).Conclusions The status of glycemic control of patients with T2DM treated with OADs only is undesirable in China.Efforts in providing professional education on management of T2DM and adjusting treatment regimen in time are needed to improve glycemic control.